Reversing USPTO Appellate Board Ruling: Not An Easy Task
In In re Droge, the federal circuit upheld the decision of the U.S. Patent and Trademark Office Board of Patent Appeals and Interferences that found that claims directed to recombinant biotechnology...To view the full article, register now.
Already a subscriber? Click here to view full article